Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets close in 2 hours 41 minutes
ALL ORDS
7,998.30
+46.00
(+0.58%)
ASX 200
7,725.40
+43.00
(+0.56%)
AUD/USD
0.6628
+0.0003
(+0.04%)
OIL
78.76
+0.28
(+0.36%)
GOLD
2,331.90
+0.70
(+0.03%)
Bitcoin AUD
95,019.74
-1,367.54
(-1.42%)
AN2 Therapeutics, Inc. (ANTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5900
+0.0300
(+1.17%)
At close: 04:00PM EDT
2.5900
0.00
(0.00%)
After hours:
04:02PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
54,871
54,871
29,511
16,906
6,019
Selling general and administrative
14,764
14,764
12,751
4,668
1,265
Total operating expenses
69,635
69,635
42,262
21,574
7,284
Operating income or loss
-69,635
-69,635
-42,262
-21,574
-7,284
Total other income/expenses net
4,903
4,903
1,306
-38
-6,322
Income before tax
-64,732
-64,732
-40,956
-21,543
-13,603
Income from continuing operations
-64,732
-64,732
-40,956
-21,543
-13,603
Net income
-64,732
-64,732
-40,956
-21,543
-13,603
Net income available to common shareholders
-64,732
-64,732
-42,776
-28,058
-13,603
Basic EPS
-2.80
-
-2.79
-1.55
-0.97
Diluted EPS
-2.80
-
-2.79
-1.55
-0.97
Basic average shares
20,999
-
15,340
18,140
14,048
Diluted average shares
20,999
-
15,340
18,140
14,048
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.